ロード中...
Revisiting pars plana vitrectomy in the primary treatment of diabetic macular edema in the era of pharmacological treatment
Diabetic macular edema (DME) is the most common cause of moderate visual loss in diabetic patients. The current treatment of choice for center-involved DME is anti-vascular endothelial growth factor (VEGF) treatment. Most patients that undergo pharmacological inhibition with anti-VEGF agents need mu...
保存先:
| 出版年: | Taiwan J Ophthalmol |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Wolters Kluwer - Medknow
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6947753/ https://ncbi.nlm.nih.gov/pubmed/31942427 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/tjo.tjo_61_19 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|